Design
Review
Authors
Loading...
Informs antiplatelet drug development; leaves open selective pathway targeting in clinical trials.
Key points are not available for this paper at this time.
Stefan Offermanns (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: